Infinity Pharmaceuticals Inc (INFIQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,369 | -26,544 | -5,917 | -4,548 | -34,088 |
| Depreciation Amortization | 3,869 | 3,078 | N/A | 1,313 | 3,866 |
| Accounts receivable | 2,500 | 2,500 | N/A | 7,078 | -2,500 |
| Accounts payable and accrued liabilities | N/A | -426 | N/A | N/A | 363 |
| Other Working Capital | 4,399 | 2,790 | -513 | 6,649 | 487 |
| Other Operating Activity | -1,736 | -1,918 | 10,062 | -4,469 | 2,401 |
| Operating Cash Flow | $-27,336 | $-20,521 | $3,633 | $6,022 | $-29,472 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 17,904 | 13,019 | 15,703 | 17,444 | 8,964 |
| PPE Investments | -2,327 | -2,266 | N/A | -486 | -3,378 |
| Purchase Sale Intangibles | N/A | N/A | N/A | -2 | N/A |
| Other Investing Activity | 0 | 0 | -3,747 | -616 | 0 |
| Investing Cash Flow | $15,576 | $10,753 | $11,956 | $16,341 | $5,586 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | -146 | N/A | N/A | N/A |
| Debt Issued | 2,003 | 1,865 | N/A | N/A | 4,199 |
| Debt Repayment | -5,557 | -4,177 | -70 | N/A | -4,493 |
| Common Stock Issued | 342 | 181 | 221 | 153 | 96 |
| Common Stock Repurchased | -44 | -44 | N/A | N/A | -35 |
| Other Financing Activity | -175 | 7 | 0 | 0 | 25,158 |
| Financing Cash Flow | $-3,431 | $-2,315 | $151 | $153 | $24,925 |
| Exchange Rate Effect | N/A | N/A | 27 | -3 | N/A |
| Beginning Cash Position | 24,634 | 24,634 | 13,148 | 13,148 | 23,594 |
| End Cash Position | 9,443 | 12,551 | 28,915 | 35,662 | 24,634 |
| Net Cash Flow | $-15,191 | $-12,083 | $15,767 | $22,514 | $1,040 |
| Free Cash Flow | |||||
| Operating Cash Flow | -27,336 | -20,521 | 3,633 | 6,022 | -29,472 |
| Capital Expenditure | -2,348 | -2,275 | N/A | -486 | -3,461 |
| Free Cash Flow | -29,685 | -22,796 | 3,633 | 5,536 | -32,933 |